• Je něco špatně v tomto záznamu ?

Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens

M. Cervinkova, P. Kucerova, J. Cizkova,

. 2017 ; 28 (8) : 819-830.

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016550

Malignant melanoma (MM) is the most aggressive and uneasily treatable form of skin cancer. Up to 90% of deaths because of skin tumours are estimated to be caused by this malignancy. Spontaneous regression is described as a partial or complete disappearance of cancer. It can be defined if the clinical and histological diagnosis of malignancy is verified and any therapeutic intervention potentially inducing mechanisms leading to regression has not been applied. Regression occurs more frequently in melanoma than in other types of tumours; it is reported to be six times higher than in other malignancies. Up to 50% of primary MM is reported to undergo spontaneous regression. However, spontaneous regression of the metastatic form of tumour is a rare phenomenon observed in only 0.23% of cases. The most frequently mentioned factors leading to spontaneous regression of MM are operative trauma, infection, vaccination (BCG and rabies vaccines) and immunological factors. Other well-documented circumstances associated with regression of metastatic MM include blood transfusion and various endocrine factors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016550
003      
CZ-PrNML
005      
20180517110106.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/CAD.0000000000000526 $2 doi
035    __
$a (PubMed)28609309
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Cervinkova, Monika $u aLaboratory of Tumour Biology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, v.v.i., Libechov bDepartment of Surgery, 1st Medical Faculty, Charles University and Hospital Na Bulovce cDepartment of Veterinary Sciences, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Prague, Czech Republic.
245    10
$a Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens / $c M. Cervinkova, P. Kucerova, J. Cizkova,
520    9_
$a Malignant melanoma (MM) is the most aggressive and uneasily treatable form of skin cancer. Up to 90% of deaths because of skin tumours are estimated to be caused by this malignancy. Spontaneous regression is described as a partial or complete disappearance of cancer. It can be defined if the clinical and histological diagnosis of malignancy is verified and any therapeutic intervention potentially inducing mechanisms leading to regression has not been applied. Regression occurs more frequently in melanoma than in other types of tumours; it is reported to be six times higher than in other malignancies. Up to 50% of primary MM is reported to undergo spontaneous regression. However, spontaneous regression of the metastatic form of tumour is a rare phenomenon observed in only 0.23% of cases. The most frequently mentioned factors leading to spontaneous regression of MM are operative trauma, infection, vaccination (BCG and rabies vaccines) and immunological factors. Other well-documented circumstances associated with regression of metastatic MM include blood transfusion and various endocrine factors.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a melanom $x imunologie $7 D008545
650    _2
$a melanomové antigeny $x imunologie $7 D058950
650    _2
$a spontánní regrese nádoru $x imunologie $7 D009365
650    _2
$a nádory kůže $x imunologie $7 D012878
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kucerova, Petra
700    1_
$a Cizkova, Jana
773    0_
$w MED00179775 $t Anti-cancer drugs $x 1473-5741 $g Roč. 28, č. 8 (2017), s. 819-830
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28609309 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517110242 $b ABA008
999    __
$a ok $b bmc $g 1300174 $s 1013390
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 28 $c 8 $d 819-830 $i 1473-5741 $m Anticancer Drugs $n Anticancer Drugs $x MED00179775
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...